In vitro characterizations of mesoporous hydroxyapatite as a controlled release delivery device for VEGF in orthopedic applications

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 11, 2012, Pages 3143-3150

  Poh, Chye Khoon ^a   Ng, Suxiu ^b   Lim, Tee Yong ^a   Tan, Hark Chuan ^a   Loo, Joachim ^b   Wang, Wilson ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Mesoporous hydroxyapatite; Orthopedic; Revascularization; VEGF

Indexed keywords

BONE; CELL ADHESION; CELL PROLIFERATION; GAS ADSORPTION; INFRARED SPECTROSCOPY; MESOPOROUS MATERIALS; ORTHOPEDICS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BONE IMPLANT; BONE REGENERATION; BONE-IMPLANT INTERFACES; CONTROLLED RELEASE; DELIVERY DEVICE; FIELD EMISSION SCANNING ELECTRON MICROSCOPES; FOURIER TRANSFORMED INFRARED SPECTROSCOPY; HIGH SURFACE AREA; IMPLANT FAILURES; IN-VITRO; ISCHEMIC CONDITIONS; MESOPOROUS; MESOSTRUCTURED MATERIALS; NATURALLY OCCURRING; NITROGEN ADSORPTION; ORTHOPEDIC APPLICATIONS; OSSEOINTEGRATION; REVASCULARIZATION; TRANSMISSION ELECTRON MICROSCOPE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR SUPPLY; VEGF;

HYDROXYAPATITE;

ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; HYDROXYAPATITE; NITROGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADSORPTION; ARTICLE; BONE IMPLANT; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; GENE SEQUENCE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; POROSITY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 84869090789     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34252     Document Type: Article

References (29)

1. Yu H, Vande Vord PJ, Mao L, Matthew HW, Wooley PH, Yang SY. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials 2009;30:508-517.
2. Lu C, Miclau T, Hu D, Marcucio RS. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 2007;25:51-61. (Pubitemid 46070731)
3. de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, Biessen EA, Rabelink TJ, van Zonneveld AJ. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol 2006;26:1653-1659. (Pubitemid 44288997)
4. Matsumoto T, Kuroda R, Mifune Y, Kawamoto A, Shoji T, Miwa M, Asahara T, Kurosaka M. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone 2008;43:434-439.
5. Freed LE, Guilak F, Guo XE, Gray ML, Tranquillo R, Holmes JW, Radisic M, Sefton MV, Kaplan D, Vunjak-Novakovic G. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 2006;12:3285-3305. (Pubitemid 46037157)
6. Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, Torio-Padron N, Schramm R, Rucker M, Junker D, Haufel JM, Carvalho C, Heberer M, Germann G, Vollmar B, Menger MD. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006;12:2093-2104. (Pubitemid 44734969)
7. Boontheekul T, Mooney DJ. Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 2003;14:559-565. (Pubitemid 37298044)
8. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25. (Pubitemid 27076453)
9. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 30-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998;273:30336-30343. (Pubitemid 28545503)
10. Alon T, Hemo I, Itin A, Peér J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
11. Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R, Amedee J. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 2002;282:C775-C785. (Pubitemid 34663140)
12. Mayr-wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002;30:472-477. (Pubitemid 34204121)
13. Ng S, Guo J, Ma J, Loo SC. Synthesis of high surface area mesostructured calcium phosphate particles. Acta Biomater 2010;6:3772-3781.
14. Yan XX, Deng HX, Huang XH, Lu GQ, Qiao SZ, Zhao DY, Yu CZ. Mesoporous bioactive glasses. I. Synthesis and structural characterization. J Non-Cryst Solids 2005;351:3209-3217. (Pubitemid 41394200)
15. Wang HL, Zhai LF, Li YH, Shi TJ. Preparation of irregular mesoporous hydroxyapatite. Mater Res Bull 2008;43:1607-1614.
16. Rehman I, Bonfield W. Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy. J Mater Sci: Mater Med 1997;8:1-4. (Pubitemid 27042279)
17. Chang MC, Tanaka J. FT-IR study for hydroxyapatite/collagen nanocomposite cross-linked by glutaraldehyde. Biomaterials 2002;23:4811-4818. (Pubitemid 35286702)
18. Loo SCJ, Siew YE, Ho S, Boey FYC, Ma J. Synthesis and hydrothermal treatment of nanostructured hydroxyapatite of controllable sizes. J Mater Sci: Mater Med 2008;19:1389-1397. (Pubitemid 351337501)
19. Posner AS, Perloff A, Diorio AF. Refinement of the hydroxyapatite structure. Acta Crystallogr 1958;11:308-309.
20. Lim TY, Poh CK, Wang W. Poly (lactic-co-glycolic acid) as a controlled release delivery device. J Mater Sci Mater Med 2009;20:1669-1675.
21. Steens W, Schneeberger AG, Skripitz R, Fennema P, Goetze C. Bone remodeling in proximal HA-coated versus uncoated cementless SL-Plus ((R)) femoral components: a 5-year follow-up study. Arch Orthop Trauma Surg 2010;130:921-926.
22. Yang GL, He FM, Hu JA, Wang XX, Zhao SF. Biomechanical comparison of biomimetically and electrochemically deposited hydroxyapatitecoated porous titanium implants. J Oral Maxillofac Surg 2010;68:420-427.
23. Zhang C, Li C, Huang S, Hou Z, Cheng Z, Yang P, Peng C, Lin J. Self-Activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials 2010;31:3374-3383.
24. Wei J, Chen F, Shin J-W, Hong H, Dai C, Su J, Liu C. Preparation and characterization of bioactive mesoporous wollastonite-polycaprolactone composite scaffold. Biomaterials 2009;30:1080-1088.
25. Santos MI, Reis RL. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010;10:12-27.
26. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA. Cell-based bone tissue engineering. PLoS Med 2007;4:e9:260-264.
27. Lin EH, Hassan M, Li Y, Zhao H, Nooka A, Sorenson E, Xie K, Champlin R, Wu X, Li D. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 2007;110:534-542. (Pubitemid 47106141)
28. Jackson DE. The unfolding tale of PECAM-1. FEBS Lett 2003;540:7-14. (Pubitemid 36398025)
29. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004;22:377-384. (Pubitemid 38736621)